FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3189585111> ?p ?o ?g. }

• W3189585111 abstract "Glucocorticoids could theoretically decrease breast cancer risk through their anti-inflammatory effects or increase risk through immunosuppression. However, epidemiological evidence is limited regarding the associations between glucocorticoid use and breast cancer risk.We investigated the association between systemic glucocorticoid use and breast cancer incidence in the E3N cohort, which includes 98,995 women with information on various characteristics collected from repeated questionnaires complemented with drug reimbursement data available from 2004. Women with at least two reimbursements of systemic glucocorticoids in any previous 3-month period since January 1, 2004, were defined as exposed. We considered exposure as a time-varying parameter, and we used multivariable Cox regression models to estimate hazard ratios (HRs) of breast cancer. We performed a competing risk analysis using a cause-specific hazard approach to study the heterogeneity by tumour subtype/stage/grade.Among 62,512 postmenopausal women (median age at inclusion of 63 years old), 2864 developed breast cancer during a median follow-up of 9 years (between years 2004 and 2014). Compared with non-exposure, glucocorticoid exposure was not associated with overall breast cancer risk [HR = 0.94 (0.85-1.05)]; however, it was associated with a higher risk of in situ breast cancer and a lower risk of invasive breast cancer [HRinsitu = 1.34 (1.01-1.78); HRinvasive = 0.86 (0.76-0.97); Phomogeneity = 0.01]. Regarding the risk of invasive breast cancer, glucocorticoid exposure was inversely associated with oestrogen receptor (ER)-positive breast cancer [HRER+ = 0.82 (0.72-0.94); HRER- = 1.21 (0.88-1.66); Phomogeneity = 0.03]; it was also inversely associated with the risk of stage 1 or stage 2 tumours but positively associated with the risk of stage 3/4 breast cancers [HRstage1 = 0.87 (0.75-1.01); HRstage2 = 0.67 (0.52-0.86); HRstage3/4 = 1.49 (1.02-2.20); Phomogeneity = 0.01].This study suggests that the association between systemic glucocorticoid use and breast cancer risk may differ by tumour subtype and stage." @default.
• W3189585111 created "2021-08-16" @default.
• W3189585111 creator A5002607290 @default.
• W3189585111 creator A5016527565 @default.
• W3189585111 creator A5048270403 @default.
• W3189585111 creator A5071714913 @default.
• W3189585111 creator A5073444454 @default.
• W3189585111 creator A5074815814 @default.
• W3189585111 creator A5090492717 @default.
• W3189585111 date "2021-08-02" @default.
• W3189585111 modified "2023-10-18" @default.
• W3189585111 title "Use of systemic glucocorticoids and risk of breast cancer in a prospective cohort of postmenopausal women" @default.
• W3189585111 cites W1973517281 @default.
• W3189585111 cites W1984800729 @default.
• W3189585111 cites W1992536063 @default.
• W3189585111 cites W2015766045 @default.
• W3189585111 cites W2020443955 @default.
• W3189585111 cites W2024203129 @default.
• W3189585111 cites W2035835146 @default.
• W3189585111 cites W2071109714 @default.
• W3189585111 cites W2073023604 @default.
• W3189585111 cites W2111626297 @default.
• W3189585111 cites W2146197235 @default.
• W3189585111 cites W2148718224 @default.
• W3189585111 cites W2282930302 @default.
• W3189585111 cites W2558289076 @default.
• W3189585111 cites W2587941297 @default.
• W3189585111 cites W2732241053 @default.
• W3189585111 cites W2768438149 @default.
• W3189585111 cites W280207433 @default.
• W3189585111 cites W2890787000 @default.
• W3189585111 cites W2901247168 @default.
• W3189585111 cites W2910311492 @default.
• W3189585111 cites W2912157825 @default.
• W3189585111 cites W2913412589 @default.
• W3189585111 cites W2920825919 @default.
• W3189585111 cites W2958289334 @default.
• W3189585111 cites W3096869228 @default.
• W3189585111 cites W60077963 @default.
• W3189585111 doi "https://doi.org/10.1186/s12916-021-02004-6" @default.
• W3189585111 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8330083" @default.
• W3189585111 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34340701" @default.
• W3189585111 hasPublicationYear "2021" @default.
• W3189585111 type Work @default.
• W3189585111 sameAs 3189585111 @default.
• W3189585111 citedByCount "6" @default.
• W3189585111 countsByYear W31895851112021 @default.
• W3189585111 countsByYear W31895851112022 @default.
• W3189585111 countsByYear W31895851112023 @default.
• W3189585111 crossrefType "journal-article" @default.
• W3189585111 hasAuthorship W3189585111A5002607290 @default.
• W3189585111 hasAuthorship W3189585111A5016527565 @default.
• W3189585111 hasAuthorship W3189585111A5048270403 @default.
• W3189585111 hasAuthorship W3189585111A5071714913 @default.
• W3189585111 hasAuthorship W3189585111A5073444454 @default.
• W3189585111 hasAuthorship W3189585111A5074815814 @default.
• W3189585111 hasAuthorship W3189585111A5090492717 @default.
• W3189585111 hasBestOaLocation W31895851111 @default.
• W3189585111 hasConcept C121608353 @default.
• W3189585111 hasConcept C126322002 @default.
• W3189585111 hasConcept C143998085 @default.
• W3189585111 hasConcept C188816634 @default.
• W3189585111 hasConcept C201903717 @default.
• W3189585111 hasConcept C207103383 @default.
• W3189585111 hasConcept C29456083 @default.
• W3189585111 hasConcept C44249647 @default.
• W3189585111 hasConcept C50382708 @default.
• W3189585111 hasConcept C530470458 @default.
• W3189585111 hasConcept C71924100 @default.
• W3189585111 hasConcept C72563966 @default.
• W3189585111 hasConceptScore W3189585111C121608353 @default.
• W3189585111 hasConceptScore W3189585111C126322002 @default.
• W3189585111 hasConceptScore W3189585111C143998085 @default.
• W3189585111 hasConceptScore W3189585111C188816634 @default.
• W3189585111 hasConceptScore W3189585111C201903717 @default.
• W3189585111 hasConceptScore W3189585111C207103383 @default.
• W3189585111 hasConceptScore W3189585111C29456083 @default.
• W3189585111 hasConceptScore W3189585111C44249647 @default.
• W3189585111 hasConceptScore W3189585111C50382708 @default.
• W3189585111 hasConceptScore W3189585111C530470458 @default.
• W3189585111 hasConceptScore W3189585111C71924100 @default.
• W3189585111 hasConceptScore W3189585111C72563966 @default.
• W3189585111 hasFunder F4320313933 @default.
• W3189585111 hasFunder F4320320883 @default.
• W3189585111 hasFunder F4320322363 @default.
• W3189585111 hasFunder F4320323807 @default.
• W3189585111 hasIssue "1" @default.
• W3189585111 hasLocation W31895851111 @default.
• W3189585111 hasLocation W31895851112 @default.
• W3189585111 hasLocation W31895851113 @default.
• W3189585111 hasLocation W31895851114 @default.
• W3189585111 hasLocation W31895851115 @default.
• W3189585111 hasLocation W31895851116 @default.
• W3189585111 hasOpenAccess W3189585111 @default.
• W3189585111 hasPrimaryLocation W31895851111 @default.
• W3189585111 hasRelatedWork W1985681015 @default.
• W3189585111 hasRelatedWork W2091349841 @default.
• W3189585111 hasRelatedWork W2154462701 @default.
• W3189585111 hasRelatedWork W2170012973 @default.
• W3189585111 hasRelatedWork W2803910286 @default.

• next